Ozempic Side Effects in India: What to Expect

Ozempic, Wegovy, Rybelsus and generic semaglutide all share the same molecule and, broadly, the same side-effect profile, since it's semaglutide's mechanism — slowed gastric emptying and reduced appetite — that drives them. The most frequently reported effects are:

• Nausea — the single most common, especially after a dose increase.
• Diarrhoea or constipation — either can occur, sometimes both at different points.
• Vomiting, usually alongside nausea rather than on its own.
• Indigestion, bloating and burping.
• Fatigue and headache, particularly in the early weeks.
• Injection-site reactions — mild redness or itching.

Most of these are dose-dependent: they tend to peak in the days after a dose increase and settle as your body adapts.

Not meaningfully — they're the same molecule at different doses and in different forms. Ozempic and Wegovy are injections (Wegovy at a higher 2.4 mg ceiling licensed for weight loss versus Ozempic's 2.0 mg diabetes dose); Rybelsus is a daily tablet. Higher doses tend to bring somewhat more pronounced GI effects, and the tablet form can cause more localised stomach upset for some people since it's absorbed differently. For the full brand-by-brand breakdown, see Ozempic in India: price, dose and weight loss and semaglutide in India: generics and price.

Generic semaglutide, now widely available in India since the patent expired, carries the same side-effect profile as the branded versions — it's the same active molecule.

Semaglutide is started low and increased gradually over several weeks for a reason: slow titration is the single most effective way to keep nausea and other GI effects manageable. Rushing the dose, or self-adjusting without medical guidance, is the most common reason people feel unwell on it. This is exactly why a clinician sets and adjusts your schedule rather than you following a generic timetable.

Eat smaller portions and stop before you feel full; favour bland, lower-fat foods when nausea is strong; stay hydrated, especially if you have diarrhoea or vomiting; and keep your protein intake up, since it protects muscle as you lose weight. Don't increase your dose if you're still struggling — tell your doctor first.

For a detailed, India-specific food-by-food approach — including what tends to be easier or harder to tolerate — see managing GLP-1 nausea and digestion.

Serious side effects are uncommon but worth knowing. Semaglutide carries a boxed warning for thyroid C-cell tumours, seen in rodent studies, and is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Rare risks include pancreatitis, gallbladder problems, kidney issues from dehydration, and low blood sugar — particularly if combined with insulin or a sulfonylurea. A doctor screens for all of this before prescribing.

For the fuller picture on these rarer, more serious effects across the whole GLP-1 class, see GLP-1 safety risks: what's serious and what's rare.

Not directly — hair shedding and muscle loss on semaglutide are generally a response to rapid weight loss and reduced protein intake rather than the drug itself, and both are largely preventable. See why GLP-1 medicines cause hair shedding and preventing muscle loss on GLP-1 medication for the detail and the fix.

Seek medical help the same day for:

• Severe or persistent abdominal pain, especially radiating to the back (possible pancreatitis).
• Severe pain in the upper-right abdomen, fever, or yellowing of the skin or eyes (possible gallbladder disease).
• Signs of an allergic reaction — facial or throat swelling, difficulty breathing.
• Symptoms of dehydration from persistent vomiting or diarrhoea.
• Signs of low blood sugar if you also take insulin or a sulfonylurea.

Never source semaglutide without a valid prescription — it is a Schedule H medicine in India, and unverified sellers cannot guarantee the molecule, dose or cold chain.